Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Veritas In Silico Inc. ( (JP:130A) ) has provided an update.
Veritas In Silico Inc. announced the relocation of its Shin-Kawasaki Research Institute to a new facility in Kawasaki City, scheduled for mid-March 2026. This move aims to support the company’s growing research initiatives and infrastructure expansion. The relocation costs have been accounted for in the current financial forecast, and the company anticipates no significant impact on its financial position or business results.
More about Veritas In Silico Inc.
Veritas In Silico Inc. operates in the biotechnology industry, focusing on drug discovery and development. The company is enhancing its research capabilities by expanding AI technology, increasing its team of researchers, and upgrading its research equipment.
Average Trading Volume: 274,536
Technical Sentiment Signal: Hold
Current Market Cap: Yen4.67B
See more insights into 130A stock on TipRanks’ Stock Analysis page.